Analyst Price Targets — INGR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 5, 2026 12:42 pm | — | UBS | $124.00 | $119.96 | TheFly | Ingredion price target raised to $124 from $119 at UBS |
| February 4, 2026 10:52 am | — | Barclays | $128.00 | $120.41 | TheFly | Ingredion price target raised to $128 from $124 at Barclays |
| November 6, 2025 9:49 am | — | Industrial Alliance Securities | $124.00 | $107.70 | TheFly | Ingredion downgraded to Equal Weight from Overweight at Barclays |
| November 5, 2025 12:29 pm | Andrew Strelzik | BMO Capital | $123.00 | $107.02 | TheFly | Ingredion price target lowered to $123 from $143 at BMO Capital |
| October 22, 2025 1:59 pm | — | Oppenheimer | $136.00 | $120.93 | TheFly | Ingredion price target lowered to $136 from $157 at Oppenheimer |
| October 6, 2025 1:53 pm | — | UBS | $130.00 | $120.42 | TheFly | Ingredion price target lowered to $130 from $144 at UBS |
| April 22, 2025 11:54 am | — | UBS | $155.00 | $130.77 | TheFly | Ingredion price target lowered to $155 from $167 at Oppenheimer |
| April 22, 2025 11:54 am | Kristen Owen | Oppenheimer | $155.00 | $130.77 | TheFly | Ingredion price target lowered to $155 from $167 at Oppenheimer |
| October 21, 2024 7:33 am | Kristen Owen | Oppenheimer | $147.00 | $134.12 | StreetInsider | Ingredion (INGR) PT Raised to $147 at Oppenheimer |
| August 9, 2024 4:37 am | Benjamin Theurer | Barclays | $145.00 | $126.76 | TheFly | Ingredion upgraded to Overweight from Equal Weight at Barclays |
Latest News for INGR
James P. Zallie sold 9,958 shares for a transaction value of ~$1.16 million based on the reported price of $116.55 per share on Feb. 18, 2026. This sale represented 23.2% of Zallie's direct holdings, reducing his direct stake from 42,968 to 33,010 shares.
Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipients DOWNERS GROVE, Ill., Feb. 24, 2026 /PRNewswire/ -- Univar Solutions LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, today announced that its Ingredients + Specialties from Univar Solutions…
Hillsdale Investment Management Inc. boosted its holdings in Ingredion Incorporated (NYSE: INGR) by 26.8% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,830 shares of the company's stock after acquiring an additional 6,100 shares during the quarter. Hillsdale Investment Management Inc.'s holdings
Dover Advisors LLC bought a new stake in Ingredion Incorporated (NYSE: INGR) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 14,000 shares of the company's stock, valued at approximately $1,710,000. A number of other large investors also recently bought and sold
Ingredion's President and CEO sold 33,597 direct shares for a transaction value of approximately $4.02 million on Feb. 11, 2026. The sale represented 40.11% of Mr.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for INGR.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.